|
TMSB15B expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.07123207474069E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.91760052281609E-10 |
| Normal-vs-Stage2 |
2.648400E-02 |
| Normal-vs-Stage3 |
1.182160E-02 |
| Normal-vs-Stage4 |
5.610200E-02 |
| Stage1-vs-Stage2 |
9.553800E-01 |
| Stage1-vs-Stage3 |
3.468300E-02 |
| Stage1-vs-Stage4 |
3.403800E-02 |
| Stage2-vs-Stage3 |
3.158400E-01 |
| Stage2-vs-Stage4 |
2.159200E-01 |
| Stage3-vs-Stage4 |
6.802800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.00589536700113E-11 |
| Normal-vs-AfricanAmerican |
2.97110000002654E-06 |
| Normal-vs-Asian |
2.636400E-01 |
| Caucasian-vs-AfricanAmerican |
4.310000E-01 |
| Caucasian-vs-Asian |
8.636200E-01 |
| AfricanAmerican-vs-Asian |
9.734000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.67589999655604E-08 |
| Normal-vs-Female |
2.74940070710272E-11 |
| Male-vs-Female |
2.470599999993E-05 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.7342999999932E-05 |
| Normal-vs-Extreme_Weight |
4.54150000051001E-07 |
| Normal-vs-Obese |
9.54080000004076E-07 |
| Normal-vs-Extreme_Obese |
1.690550E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.561400E-01 |
| Normal_Weight-vs-Obese |
2.776200E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.176600E-01 |
| Extreme_Weight-vs-Obese |
2.568400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.927800E-01 |
| Obese-vs-Extreme_Obese |
4.041600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.105800E-02 |
| Normal-vs-Age(41-60Yrs) |
2.90749646580934E-11 |
| Normal-vs-Age(61-80Yrs) |
7.29049998149378E-09 |
| Normal-vs-Age(81-100Yrs) |
3.016400E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.558000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.585200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.438600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.843400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.756000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.213600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.68673971959288E-14 |
| Normal-VS-Type2 PRCC |
1.088210E-02 |
| Normal-VS-KIRP CIMP |
5.202400E-01 |
| Normal-VS-Unclassified PRCC |
1.760470E-04 |
| Type1 PRCC-VS-Type2 PRCC |
9.0913999994946E-07 |
| Type1 PRCC-VS-KIRP CIMP |
4.129600E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
4.617600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.072000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
9.698400E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
1.165190E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.877830E-03 |
| Normal-vs-N1 |
4.682800E-03 |
| Normal-vs-N2 |
1.996370E-02 |
| N0-vs-N1 |
9.197000E-01 |
| N0-vs-N2 |
9.470200E-01 |
| N1-vs-N2 |
9.766400E-01 |
|
|
